Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriaki Hosoya

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Protein & Cell|January 5, 2011
HIV-1 tropismAikichi Iwamoto, Noriaki Hosoya, Ai Kawana-Tachikawa
Journal of Medical Virology|June 10, 2003
Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapyToshiyuki Miura, Mieko Goto, Noriaki Hosoya, et al.
Journal of Medical Virology|April 22, 2006
Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trialFuyuaki Ide, Tetsuya Nakamura, Mariko Tomizawa, et al.
The Journal of Infectious Diseases|July 9, 2014
Epigenetic repression of interleukin 2 expression in senescent CD4+ T cells during chronic HIV type 1 infectionKaori Nakayama-Hosoya, Takaomi Ishida, Ben Youngblood, et al.
Journal of Virology|April 1, 2016
Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral TherapyAya Ishizaka, Hidenori Sato, Hitomi Nakamura, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 30, 2010
Long-term successful control of super-multidrug-resistant human immunodeficiency virus type 1 infection by a novel combination therapy of raltegravir, etravirine, and boosted-darunavirHitomi Nakamura, Naoko Miyazaki, Noriaki Hosoya, et al.
Journal of Virology|July 29, 2004
Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese populationTae Furutsuki, Noriaki Hosoya, Ai Kawana-Tachikawa, et al.
Vaccine|April 17, 2012
Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adultsTadashi Kikuchi, Kiyoko Iwatsuki-Horimoto, Eisuke Adachi, et al.
Journal of the International AIDS Society|September 21, 2013
Development of a rapid cell-fusion-based phenotypic HIV-1 tropism assayPhairote Teeranaipong, Noriaki Hosoya, Ai Kawana-Tachikawa, et al.
Journal of Clinical Microbiology|June 5, 2009
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virionsNoriaki Hosoya, Zhaohui Su, Timothy Wilkin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Protein & Cell|January 5, 2011
HIV-1 tropismAikichi Iwamoto, Noriaki Hosoya, Ai Kawana-Tachikawa
Journal of Medical Virology|June 10, 2003
Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapyToshiyuki Miura, Mieko Goto, Noriaki Hosoya, et al.
Journal of Medical Virology|April 22, 2006
Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trialFuyuaki Ide, Tetsuya Nakamura, Mariko Tomizawa, et al.
The Journal of Infectious Diseases|July 9, 2014
Epigenetic repression of interleukin 2 expression in senescent CD4+ T cells during chronic HIV type 1 infectionKaori Nakayama-Hosoya, Takaomi Ishida, Ben Youngblood, et al.
Journal of Virology|April 1, 2016
Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral TherapyAya Ishizaka, Hidenori Sato, Hitomi Nakamura, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 30, 2010
Long-term successful control of super-multidrug-resistant human immunodeficiency virus type 1 infection by a novel combination therapy of raltegravir, etravirine, and boosted-darunavirHitomi Nakamura, Naoko Miyazaki, Noriaki Hosoya, et al.
Journal of Virology|July 29, 2004
Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese populationTae Furutsuki, Noriaki Hosoya, Ai Kawana-Tachikawa, et al.
Vaccine|April 17, 2012
Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adultsTadashi Kikuchi, Kiyoko Iwatsuki-Horimoto, Eisuke Adachi, et al.
Journal of the International AIDS Society|September 21, 2013
Development of a rapid cell-fusion-based phenotypic HIV-1 tropism assayPhairote Teeranaipong, Noriaki Hosoya, Ai Kawana-Tachikawa, et al.
Journal of Clinical Microbiology|June 5, 2009
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virionsNoriaki Hosoya, Zhaohui Su, Timothy Wilkin, et al.
Pageof 2